Manufacturers announce positive results for Dextenza (corticosteroid intracanalicular insert) for ocular itching associated with allergic conjunctivitis in phase III trial

In RCT (n=96) of thisinsert designed to release dexamethasone to eye for up to 30 days, all pre-specified primary endpoints were met, as shown by statistically significant mean change in ocular itching from baseline., on subject-reported 5-point scale, at 3 time points on Day 8.


Biospace Inc.